Legend Biotech to Host Investor Conference Call on Fourth Quarter and Full Year 2025 Results

Company Overview - Legend Biotech Corporation is a global leader in cell therapy with over 2,900 employees, making it the largest standalone cell therapy company [3] - The company is pioneering treatments that significantly change cancer care, particularly through its CAR-T cell therapy, CARVYKTI, which is a one-time treatment for relapsed or refractory multiple myeloma [3] - Legend Biotech collaborates with Johnson & Johnson for the development and marketing of CARVYKTI and aims to maximize patient access and therapeutic potential [3] Upcoming Financial Event - Legend Biotech will host a conference call for investors on March 10, 2026, at 8:00 am ET to review the fourth-quarter and full-year 2025 financial results [1] - Senior management will provide an overview of the company's quarterly and full-year financial performance during the call [1] Investor Relations - Investors can access the live audio webcast of the conference call via a provided weblink, and a replay will be available in the Investor Relations section of the Legend Biotech website approximately two hours after the call [2]